Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects

Wang Hongyun; Lang Liwei; Ou Ning; Shi Ruihua; Hu Haitang; Hu Pei; Jiang Ji

首页> 外文期刊>Clinical drug investigation >Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects

【24h】

Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects

机译：多次输注伊拉唑在中国健康人群中的药代动力学，药效学和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and Objectives Ilaprazole is a novel proton pump inhibitor that provides effective and long lasting inhibition of intragastric acid secretion. The objectives of this study were to investigate the pharmacokinetics, pharmacodynamics, and safety of intravenous ilaprazole after multiple administrations in healthy Chinese subjects.

机译：背景与目的依拉拉唑是一种新型的质子泵抑制剂，可有效，持久地抑制胃内酸的分泌。这项研究的目的是研究在健康的中国受试者中多次给药后静脉注射艾拉帕唑的药代动力学，药效学和安全性。

著录项

来源
《Clinical drug investigation》 |2016年第6期|共8页
作者
Wang Hongyun; Lang Liwei; Ou Ning; Shi Ruihua; Hu Haitang; Hu Pei; Jiang Ji;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects [J] . Wang Hongyun, Lang Liwei, Ou Ning, Clinical drug investigation . 2016,第6期

机译：多次输注伊拉唑在中国健康人群中的药代动力学，药效学和安全性
2. Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects [J] . Tsuda Yasuhiro, Grimaldi Christine, Huang Fenglei, British Journal of Clinical Pharmacology . 2021,第4期

机译：BI 655064的安全，药代动力学和药效学在健康汉语和日本科目中的1阶段临床试验中
3. Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects [J] . Yasuhiro Tsuda, Christine Grimaldi, Fenglei Huang, British journal of clinical pharmacology . 2021,第4期

机译：BI 655064的安全，药代动力学和药效学在健康汉语和日本科目中的1阶段临床试验中
4. Safety, tolerability, pharmacodynamics and pharmacokinetics following single subcutaneous dosesof a teverelix depot formulation in healthy male volunteers [C] . C. MacLean, F. Larsen, R. Piechatzek, Annual meeting exposition of the Controlled Release Society . 2005

机译：在健康男性志愿者中单次皮下注射Teverelix储库制剂后的安全性，耐受性，药效动力学和药代动力学
5. Pharmacokinetic/Pharmacodynamic Analyses of Avatrombopag in Healthy Subjects and Patients with Chronic Liver Disease [D] . NOMOTO, Maiko 2019

机译：阿法曲巴帕在健康受试者和慢性肝病患者中的药代动力学/药效学分析
6. Single- and multiple-dose pharmacokinetics pharmacodynamics and safety of apixaban in healthy Chinese subjects Corrigendum [O] . 2014

机译：阿哌沙班在中国健康受试者中的单剂量和多剂量药代动力学药效学和安全性勘误
7. Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects [O] . Yasuhiro Tsuda, Christine Grimaldi, Fenglei Huang, 2020

机译：BI 655064的安全，药代动力学和药效学和健康中日教临床试验中的临床试验

Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects

摘要

著录项

相似文献

相关主题

期刊订阅